Latest filing published 14 Mar 2024 for Akoya Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert G. Shepler: trading record in brief
Robert G. Shepler, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in LDR Holding Corp and Akoya Biosciences, Inc. We count 92 filings; the first trade dates from 15 October 2013 and the latest from 13 March 2024.
The open-market side counts 7 purchases for €1.5M alongside 75 sales for €22.5M. The net balance comes to €21.0M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €161k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 14 March 2024 came the latest disclosure, a transaction in Akoya Biosciences, Inc. The clock since the last published purchase (12 June 2023) now reads 1,246 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert G. Shepler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 369,592 shares0Common StockSEC:0001104659-24-034667:1
- 369,592 shares0Common StockSEC:0001104659-24-034667:0
- 120,000 shares@ US$5.0077.6% of flowCommon StockSEC:0001104659-23-070480:0Canonical exit: 10 Sept 2023 (T+90)
- 20,000 shares@ US$12.9324.1% of flowCommon StockSEC:0001104659-21-141484:1Canonical exit: 16 Feb 2022 (T+90)
- 15,000 shares@ US$12.16722.4% of flowCommon StockSEC:0001104659-21-141484:0Canonical exit: 16 Feb 2022 (T+90)
- 107,102 shares@ US$37.67Common StockSEC:0001209191-15-017447:0
- 36,168 shares@ US$37.63Common StockSEC:0001209191-15-017447:1
- 42,287 shares@ US$39.17Common StockSEC:0001209191-15-017447:2
- 2,899 shares@ US$37.67Common StockSEC:0001209191-15-017447:3
- 979 shares@ US$37.63Common StockSEC:0001209191-15-017447:4
- 1,145 shares@ US$39.17Common StockSEC:0001209191-15-017447:5
- 15,552 shares@ US$37.67Common StockSEC:0001209191-15-017447:6
- 5,252 shares@ US$37.63Common StockSEC:0001209191-15-017447:7
- 6,140 shares@ US$39.17Common StockSEC:0001209191-15-017447:8
- 669 shares@ US$37.67Common StockSEC:0001209191-15-017447:9
- 226 shares@ US$37.63Common StockSEC:0001209191-15-017447:10
- 264 shares@ US$39.17Common StockSEC:0001209191-15-017447:11
- 2,357 shares@ US$37.67Common StockSEC:0001209191-15-017447:12
- 796 shares@ US$37.63Common StockSEC:0001209191-15-017447:13
- 931 shares@ US$39.17Common StockSEC:0001209191-15-017447:14
- 17,782 shares@ US$31.54Common StockSEC:0001209191-14-060705:0
- 5,437 shares@ US$31.35Common StockSEC:0001209191-14-060705:1
- 167 shares@ US$31.25Common StockSEC:0001209191-14-060705:2
- 481 shares@ US$31.54Common StockSEC:0001209191-14-060705:3
- 147 shares@ US$31.35Common StockSEC:0001209191-14-060705:4
25 of 47 declarations